RE:RE:RE:RE:Where does these shares come from to payout Careoncology? Omg. I can't fix stupid or teach business to this board.
1. you realize for a private company there are ways to be creative to show a smaller or no profit to avoid tax. Executive bonus and dividends, asset purchases, employee profit share, acquisitions etc. Break even does not mean unprofitable. And what is Exas profit to revenue Lol You have obviously never run or been an executive in a company before
2 with stage bringing in the Care revenue it does not mean all the Care costs. There will be economies of scale and synergies that will be much less cost than a stand alone company would incur.
3 the companies will bring additional clients from both sides of the business to add to overall revenues.
All this for a 1 year ROI. To suggest a $2 a share bonus for milestones I imagine there are significant revenue targets set out and the UK licenses should pay for themselves
Multiple clinics with existing clients for $4.7 million and $4 million in annual revenue and growing All day long
Liked2Think wrote: what about the 2,500,000 shares for UK licensing which hey I agree its probably worth that so thats fine.
Then the myster 8,000,000 for milestones that we have no idea what they are and if not 8M shares then $16M dollars. So those milestones are worth $16M or do they think shares will be worth $2 ea by then. Is this why Tripp wanted the 2:1 RS recently to get the SP to that level?
So assuming all "milestones" are achieved and if we use the current price of $0.38 (which more realistically it is at $0.42-$0.44 a share when signed then everything comes to anywhere from $8.7M to $21.7M Stage will pay for Care and Care's milestones.
Pretty good for a company that makes $0.